Abstract:Bacillus anthracis causes anthrax disease and exerts its deleterious effects by the release of three exotoxins, i.e. lethal factor, protective antigen and edema factor (EF), a highly active calmodulin-dependent adenylyl cyclase (AC). Conventional antibiotic treatment is ineffective against either toxaemia or antibiotic-resistant strains. Thus, more effective drugs for anthrax treatment are needed. Our previous studies showed that EF is differentially inhibited by various purine and pyrimidine nucleotides modified with N-methylanthraniloyl (MANT)- or anthraniloyl (ANT) groups at the 2′(3′)-O-ribosyl position, with the unique preference for the base cytosine (Taha et al., Mol Pharmacol 75:693 (2009)). MANT-CTP was the most potent EF inhibitor (K i, 100 nM) among 16 compounds studied. Here, we examined the interaction of EF with a series of 18 2′,3′-O-mono- and bis-(M)ANT-substituted nucleotides, recently shown to be very potent inhibitors of the AC toxin from Bordetella pertussis, CyaA (Geduhn et al., J Pharmacol Exp Ther 336:104 (2011)). We analysed purified EF and EF mutants in radiometric AC assays and in fluorescence spectroscopy studies and conducted molecular modelling studies. Bis-MANT nucleotides inhibited EF competitively. Propyl-ANT-ATP was the most potent EF inhibitor (K i, 80 nM). In contrast to the observations made for CyaA, introduction of a second (M)ANT-group decreased rather than increased inhibitor potency at EF. Activation of EF by calmodulin resulted in effective fluorescence resonance energy transfer (FRET) from tryptophan and tyrosine residues located in the vicinity of the catalytic site to bis-MANT-ATP, but FRET to bis-MANT-CTP was only small. Mutations N583Q, K353A and K353R differentially altered the inhibitory potencies of bis-MANT-ATP and bis-MANT-CTP. The nucleotide binding site of EF accommodates bulky bis-(M)ANT-substituted purine and pyrimidine nucleotides, but the fit is suboptimal compared to CyaA. These data provide a basis for future studies aiming at the development of potent EF inhibitors with high selectivity relative to mammalian ACs.

Structural and Kinetic Analyses of the Interaction of Anthrax Adenylyl Cyclase Toxin with Reaction Products Camp and Pyrophosphate

Structure of Anthrax Edema Factor–calmodulin–adenosine 5′-(Α,β-methylene)-triphosphate Complex Reveals an Alternative Mode of ATP Binding to the Catalytic Site

Calcium-Independent Calmodulin Binding and Two-Metal-Ion Catalytic Mechanism of Anthrax Edema Factor

Molecular Analysis of the Interaction of Anthrax Adenylyl Cyclase Toxin, Edema Factor, with 2 '(3 ')-O-(n-(methyl)anthraniloyl)-substituted Purine and Pyrimidine Nucleotides

Structural Basis for the Activation of Anthrax Adenylyl Cyclase Exotoxin by Calmodulin

Distinct interactions of 2'- and 3'-O-(N-methyl)anthraniloyl-isomers of ATP and GTP with the adenylyl cyclase toxin of Bacillus anthracis, edema factor.

Physiological Calcium Concentrations Regulate Calmodulin Binding and Catalysis of Adenylyl Cyclase Exotoxins

Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA.

Structural Basis for the Interaction of Bordetella Pertussis Adenylyl Cyclase Toxin with Calmodulin.

Structural Insights into the Enzymatic Mechanism of the Pathogenic MAPK Phosphothreonine Lyase.

Crystallization and Preliminary X-ray Study of the Edema Factor Exotoxin Adenylyl Cyclase Domain from Bacillus Anthracis in the Presence of Its Activator, Calmodulin.

Inhibition of the Adenylyl Cyclase Toxin, Edema Factor, from Bacillus Anthracis by a Series of 18 Mono- and Bis-(M)ant-substituted Nucleoside 5′-Triphosphates

Crystallization And Preliminary X-Ray Study Of The Edema Factor Exotoxin Adenylyl Cyclase Domain From Bacillus Anthracis In The Presence Of Its Activator, Calmodulin

Structure-based inhibitor discovery against adenylyl cyclase toxins from pathogenic bacteria that cause anthrax and whooping cough

Interactions of Bordetella Pertussis Adenylyl Cyclase Toxin CyaA with Calmodulin Mutants and Calmodulin Antagonists: Comparison with Membranous Adenylyl Cyclase I.

The Closed Conformation of a Highly Flexible Protein: the Structure of E. Coli Adenylate Kinase with Bound AMP and AMPPNP.

Structure Determination of the CAMP Factor Ofstreptococcus Agalactiaewith the Aid of an MBP Tag and Insights into Membrane-Surface Attachment

The 1.6 Å Resolution Structure of Activated D138L Mutant of Catabolite Gene Activator Protein with Two Camp Bound in Each Monomer

Assignment of the Nucleotide Binding Sites and the Mechanism of Substrate Inhibition of Escherichia Coli Adenylate Kinase.

Early Circulating Edema Factor in Inhalational Anthrax Infection: Does It Matter?

Molecular cloning and expression of the Bacillus anthracis edema factor toxin gene: a calmodulin-dependent adenylate cyclase